The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells

被引:11
作者
Lees, DM
Pallikaros, Z
Corder, R
机构
[1] Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
[2] Nycomed Amersham, Amersham Labs, Amersham HP7 9LL, Bucks, England
关键词
endothelin; TNF (tumor necrosis factor) receptor; endothelial cell; epithelial cell; inflammation; atherosclerosis;
D O I
10.1016/S0014-2999(00)00022-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Synthesis of the vasoconstrictor peptide endothelin-1 by endothelial and epithelial cells is strongly induced by tumor necrosis factor alpha (TNF-alpha). The actions of TNF-alpha are mediated by two transmembrane receptors of approximately 55 (p55, CD120a) and 75 kDa (p75, CD120b). Reagents activating selectively these receptor subtypes have been used to identify which TNF receptor mediates the induction of endothelin-1 synthesis. Stimulation of bovine aortic endothelial cells or human HEp-2 epithelial cells with a p55-selective mutant of human TNF-alpha (R32W-S86T) induced significant and concentration-dependent increases in endothelin-1 release. A p75 receptor-selective TNF-alpha mutant(D143N-A145R) was ineffective alone or in combination with the p55-selective mutant. Competitive binding experiments with [I-125]TNF-alpha showed the p55-selective mutant, but not the p75-selective mutant, to inhibit the binding of [I-125]TNF-alpha to endothelial and HEp-2 cells. Similar results were obtained with the p55 agonist antibody htrl in both cell lines. These results establish the p55 TNF receptor as the main receptor involved in the induction of endothelin-1 synthesis by TNF-alpha. (C) 2000 Elsevier Science B.V. Ail rights reserved.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 26 条
[1]  
Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93
[2]   DISSOCIATION OF TNF-ALPHA CYTOTOXIC AND PROINFLAMMATORY ACTIVITIES BY P55 RECEPTOR-SELECTIVE AND P75 RECEPTOR-SELECTIVE TNF-ALPHA MUTANTS [J].
BARBARA, JAJ ;
SMITH, WB ;
GAMBLE, JR ;
VANOSTADE, X ;
VANDENABEELE, P ;
TAVERNIER, J ;
FIERS, W ;
VADAS, MA ;
LOPEZ, AF .
EMBO JOURNAL, 1994, 13 (04) :843-850
[3]   THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :625-655
[4]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[5]   ELEVATED RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY BRONCHOALVEOLAR LEUKOCYTES FROM PATIENTS WITH BRONCHIAL-ASTHMA [J].
CEMBRZYNSKANOWAK, M ;
SZKLARZ, E ;
INGLOT, AD ;
TEODORCZYKINJEYAN, JA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (02) :291-295
[6]   Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors [J].
Clauss, M ;
Grell, M ;
Fangmann, C ;
Fiers, W ;
Scheurich, P ;
Risau, W .
FEBS LETTERS, 1996, 390 (03) :334-338
[7]  
CORDER R, 1995, J CARDIOVASC PHARM, V26, pS56
[8]   EFFECTS OF PHOSPHORAMIDON IN ENDOTHELIAL-CELL CULTURES ON THE ENDOGENOUS SYNTHESIS OF ENDOTHELIN-1 AND ON CONVERSION OF EXOGENOUS BIG ENDOTHELIN-1 TO ENDOTHELIN-1 [J].
CORDER, R ;
HARRISON, VJ ;
KHAN, N ;
ANGGARD, EE ;
VANE, JR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 :S73-S76
[9]   Early events in TNF signaling: A story of associations and dissociations [J].
Darnay, BG ;
Aggarwal, BB .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (05) :559-566
[10]   THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802